GOLDEN BIOTECHNOLOGY CORPORATION

Business Nature: Manufacturer (Biotechnology/Pharmaceutical company)

Company Overview:

Golden Biotechnology Corporation is a leading biopharmaceutical company based in Taiwan, dedicated to the research, development, and production of innovative small-molecule drugs and high-quality health supplements. The company operates its own R&D centers and manufacturing facilities, focusing on areas such as oncology, metabolic diseases, and inflammatory conditions. As a manufacturer, the company manages the entire value chain from drug discovery and clinical trials to the large-scale production of its proprietary pharmaceutical products and nutritional formulations. It is recognized for its commitment to rigorous scientific standards and advanced biotechnological manufacturing processes.

Golden Biotechnology Corporation focuses on the development of small molecule new drugs and health supplements. Below are their primary products:

Pharmaceutical Products:

Antroquinonol (Hocena): A primary drug candidate undergoing various clinical trials for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, and other solid tumors.

Health Supplement Products:

Antromax: A dietary supplement derived from Antrodia cinnamomea, marketed for its potential in supporting liver health, regulating physiological functions, and enhancing physical strength.

Synergy series: Various nutritional supplements formulated to support immune health and metabolic balance.

Please note that product availability and clinical status may change according to regulatory approvals and market strategies.